Skip to content
2000
Volume 23, Issue 16
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Malignancy is characterized by damage to several vital organs, and utilizing chemotherapy as a treatment option can have toxic effects on healthy body tissues. Kidney function is commonly compromised by cancer and chemotherapy. These effects can be pre-renal, intrarenal, or postrenal. Tumor lysis syndrome and electrolyte disturbances are also common in this group of patients. Etiologies of this dysfunction are poorly understood; therefore, careful monitoring and management of renal function are required in such cases. This narrative review aimed to highlight some of the common renal abnormalities among patients receiving cancer and chemotherapy.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/1871520623666230602143525
2023-10-01
2025-09-12
Loading full text...

Full text loading...

/content/journals/acamc/10.2174/1871520623666230602143525
Loading

  • Article Type:
    Review Article
Keyword(s): cancer; chemotherapy; dysfunction; kidney; Malignancy; tumor
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test